SpringerLink
Log in

Cardiac Pulmonary Edema, Chronic Heart Failure

  • Chapter
  • First Online:
Pharmacology in Noninvasive Ventilation

Part of the book series: Noninvasive Ventilation. The Essentials ((NVE))

  • 144 Accesses

Abstract

Cardiogenic pulmonary edema (CPE) is one of the outcomes of acute heart failure and is a common reason of critical condition with respiratory distress. Prompt diagnosis and treatment may prevent the main complications. Medical treatment and high-flow oxygen administration are recommended. Patients no responder to conventional therapy required advanced treatment, including inotropes.

Chronic heart failure in children implies the presence of structural remodeling of the heart. Management of these patients is based on the neuro-hormonal inhibition mechanism. Most of the recommendations for chronic pediatric HF therapy were extrapolated from adult heart failure trials. Today new drugs are emerging for chronic heart failure and cardiomyopathies, but for some of them no data are still available in children.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (France)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 160.49
Price includes VAT (France)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 210.99
Price includes VAT (France)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cleland JG, Yassin AS, Khadjooi K. Acute heart failure: focusing on acute cardiogenic pulmonary oedema. Clin Med (Lond). 2010;10(1):59–64. https://doi.org/10.7861/clinmedicine.10-1-59.

    Article  PubMed  Google Scholar 

  2. Witharana TN, Baral R, Vassiliou VS. Impact of morphine use in acute cardiogenic pulmonary oedema on mortality outcomes: a systematic review and meta-analysis. Ther Adv Cardiovasc Dis. 2022;16:17539447221087587. https://doi.org/10.1177/17539447221087587. PMID: 35343809; PMCID: PMC8966112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cekmen B, Bildik B, Bozan O, Atis SE, Dogan S, Kocak AO. Utility of non-invasive synchronized intermittent mandatory ventilation in acute cardiogenic pulmonary edema. Am J Emerg Med. 2022;56:71–6. https://doi.org/10.1016/j.ajem.2022.03.044. Epub ahead of print. PMID: 35367682.

    Article  PubMed  Google Scholar 

  4. Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359:142.

    Article  CAS  PubMed  Google Scholar 

  5. Bello G, De Pascale G, Antonelli M. Noninvasive ventilation. Clin Chest Med. 2016;37(4):711–21.

    Article  PubMed  Google Scholar 

  6. British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax. 2002;57(3):192–211. https://doi.org/10.1136/thorax.57.3.192. PMID: 11867822; PMCID: PMC1746282.

    Article  Google Scholar 

  7. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J Aug. 2017;50(2):1602426.

    Article  Google Scholar 

  8. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol. 2001;38:2101–13. https://doi.org/10.1016/s0735-1097(01)01683-7.

    Article  CAS  PubMed  Google Scholar 

  9. Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can J Cardiol. 2013;29:1535–52. https://doi.org/10.1016/j.cjca.2013.08.008.

    Article  PubMed  Google Scholar 

  10. Kirk R, Dipchand AI, Rosenthal DN, Addonizio L, Burch M, Chrisant M, et al. The International Society for Heart and Lung Transplantation guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant. 2014;33:888–909. https://doi.org/10.1016/j.healun.2014.06.002.

    Article  PubMed  Google Scholar 

  11. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Bécane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol. 2005;45(6):855–7. https://doi.org/10.1016/j.jacc.2004.09.078. PMID: 15766818.

    Article  CAS  PubMed  Google Scholar 

  12. Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, Barker PC, Ravishankar C, McCrindle BW, Williams RV, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD, Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL, Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(2):153–61. https://doi.org/10.1016/S1474-4422(14)70318-7. Epub 2014 Dec 30. Erratumin: Lancet Neurol. 2015 Feb;14(2):135. PMID: 25554404; PMCID: PMC4361281.

    Article  CAS  PubMed  Google Scholar 

  14. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171–9.

    Article  PubMed  Google Scholar 

  15. Adorisio R, Cantarutti N, Ciabattini M, Amodeo A, Drago F. Real-world use of carvedilol in children with dilated cardiomyopathy: long-term effect on survival and ventricular function. Front Pediatr. 2022;10:845406. https://doi.org/10.3389/fped.2022.845406. PMID: 35433536; PMCID: PMC9010785.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Adorisio R, Calvieri C, Cantarutti N, D’Amico A, Catteruccia M, Bertini E, et al. Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy. Int J Cardiol. 2019;280:99–103. https://doi.org/10.1016/j.ijcard.2019.01.052.

    Article  PubMed  Google Scholar 

  17. Bonnet D, Berger F, Jokinen E, Kantor PF, Daubeney PEF. Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure. J Am Coll Cardiol. 2017;70:1262–72. https://doi.org/10.1016/j.jacc.2017.07.725.

    Article  CAS  PubMed  Google Scholar 

  18. Rossano J, Kantor P, Shaddy R, Shi L, Wilkinson J, Jefferies J, et al. Increased heart rate is independently associated with worse survival in pediatric patients with dilated cardiomyopathy: a multicentre study from the pediatric cardiomyopathy registry. Eur Heart J. 2017;38:210. https://doi.org/10.1093/eurheartj/ehx502.965.

    Article  Google Scholar 

  19. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015;131:54–61. https://doi.org/10.1161/CIRCULATIONAHA.114.013748.

    Article  CAS  PubMed  Google Scholar 

  20. Shaddy R, Canter C, Halnon N, Kochilas L, Rossano J, Bonnet D, et al. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J. 2017;193:23–34. https://doi.org/10.1016/j.ahj.2017.07.006.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Cardiology and Arrhythmias/Syncope Units, Department of Cardiology, Bambino Gesù Children’s Hospital, Rome, Italy

    Nicoletta Cantarutti & Rachele Adorisio

Authors
  1. Nicoletta Cantarutti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachele Adorisio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nicoletta Cantarutti or Rachele Adorisio .

Editor information

Editors and Affiliations

  1. Intensive Care Unit, Hospital General Universitario Morales M, Murcia, Murcia, Spain

    Antonio M. Esquinas

  2. Medicine, Pulmonary Critical Care Medicine, Northern Westchester Hospital, Mount Kisco, NY, USA

    Bushra Mina

  3. Translational Medicine, University of Ferrara, Ferrara, Italy

    Savino Spadaro

  4. Anesthesiology and Pediatric Intensive Care, Bambino Gesù Children’s Hospital, Roma, Italy

    Daniela Perrotta

  5. Anesthesiology and Pediatric Intensive Care, UOC ARCO Palidoro Bambino Gesù Children's Hospital, Roma, Italy

    Francesco De Sanctis

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cantarutti, N., Adorisio, R. (2023). Cardiac Pulmonary Edema, Chronic Heart Failure. In: Esquinas, A.M., Mina, B., Spadaro, S., Perrotta, D., De Sanctis, F. (eds) Pharmacology in Noninvasive Ventilation. Noninvasive Ventilation. The Essentials. Springer, Cham. https://doi.org/10.1007/978-3-031-44626-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-44626-9_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-44625-2

  • Online ISBN: 978-3-031-44626-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation